[Vasopressin: An effective treatment for autism spectrum disorders?]

Med Sci (Paris). 2021 Oct;37(10):848-850. doi: 10.1051/medsci/2021134. Epub 2021 Oct 14.

[Article in French]

Authors

Amélie M Borie¹, Françoise Muscatelli², Michel G Desarménien³, Freddy Jeanneteau³

Affiliations

¹ Center for translational social neuroscience, Silvio O. Conte Center for oxytocin and social cognition, Yerkes national primate research center, Biology department, Emory university, 30322 Atlanta, États-Unis.
² Institut des neurosciences de la méditerranée, Inserm, Aix-Marseille université, Marseille, France.
³ Institut de génomique fonctionnelle, université de Montpellier, CNRS, Inserm, 141 rue de la Cardonille, 34090 Montpellier, France.

PMID: 34647872
DOI: 10.1051/medsci/2021134

No abstract available

MeSH terms

Autism Spectrum Disorder* / drug therapy
Humans
Vasopressins

Substances

Vasopressins

Grants and funding